Tenofovir or zidovudine in three‐drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non‐nucleoside reverse transcriptase inhibitor for initial treatment of HIV…

Overview of attention for article published in Cochrane database of systematic reviews, October 2010

Altmetric Badge

Citations

dimensions_citation: 35 Dimensions

Readers on

mendeley: 206 Mendeley
connotea: 1 Connotea

Summary Dimensions citations

So far, Dimensions has found 35 publications that cite this research output.

35

The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.

Clinical outcomes with second-line dolutegravir in people with virological failure on first-line non-nucleoside reverse transcriptase inhibitor-based regimens in South Africa: a retrospective cohort study

Article in The Lancet Global Health (December 2023)

Clinical outcomes after the introduction of dolutegravir for second-line antiretroviral therapy in South Africa: a retrospective cohort study

Preprint in medRxiv (July 2023)

HIV/AIDS Global Epidemic

Book chapter (February 2023)